Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Early identification and treatment of this inflammatory cascade using existing therapeutic
strategies with proven safety profiles could change the course and prognosis of COVID-19
infection, reducing mortality rates. Glucocorticoids may modulate inflammation-mediated lung
injury and thereby reduce progression to respiratory failure and death